Manik Madaan/med.psu.edu
Jul 6, 2026, 20:31
Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
Manik Madaan, Resident Doctor at Penn State University, shared a post on LinkedIn:
”Master Transfusion Reactions for USMLE In Less Than 60 Seconds
Acute Hemolytic Reaction (ABO mismatch)
- Mechanism: type II hypersensitivity, recipient anti-A / anti-B antibodies attack donor red blood cells – intravascular hemolysis
- Presentation: minutes to 24 hours; fever, chills, flank pain, hypotension, hemoglobinuria; can trigger DIC (disseminated intravascular coagulation)
- Tx: STOP transfusion now, IV fluids; next step – Coombs (positive)
Febrile Non-Hemolytic Reaction (most common)
- Mechanism: cytokines from donor white blood cells build up in storage (no hemolysis)
- Presentation: 1 to 6 hours; fever plus chills; Coombs negative
- Tx: stop to rule out hemolysis, then acetaminophen; prevent with leukoreduction
Allergic / Anaphylactic Reaction
- Mechanism: type I hypersensitivity to donor plasma proteins; severe equals IgA (immunoglobulin A)-deficient patient with anti-IgA antibodies
- Presentation: within minutes; mild equals hives plus itching (no fever); severe equals anaphylaxis
- Tx: antihistamines; anaphylaxis equals epinephrine; washed / IgA-free products if IgA deficient
TRALI (transfusion-related acute lung injury)
- Mechanism: donor anti-leukocyte antibodies activate lung neutrophils – non-cardiogenic pulmonary edema
- Presentation: within 6 hours; dyspnea, hypoxia, bilateral infiltrates, fever plus LOW blood pressure, normal BNP (heart-strain marker)
- Tx: stop, oxygen; top cause of transfusion death
TACO (transfusion-associated circulatory overload)
- Mechanism: too much volume too fast – cardiogenic pulmonary edema
- Presentation: after 6 hours (or heart disease); AFEBRILE plus HIGH blood pressure, high BNP, neck-vein distension
- Tx: slow or stop transfusion, sit upright, diuretics
Want more USMLE Cheatsheets?”

Stay updated with Hemostasis Today.
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood
-
Jul 6, 2026, 17:382026 ACC/AHA Multisociety Dyslipidemia Guideline: Key Updates for Vascular Specialists – Batool Abuhalimeh
-
Jul 6, 2026, 17:27Nicolas Gendron: Should Carbon Footprint Influence Therapeutic Decisions?
-
Jul 6, 2026, 17:15Sanchit Sharma։ Continuous Anticoagulation in PVT with Varices